Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban vs UFH in V-V ECMO
NCT04925167Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of argatroban in thrombosis (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: incidence of ECMO related thrombotic events at 14 days. Started Jul 2021; status: completed.
02
Drugs
argatroban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT04925167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04925167.